Treat insurance like a structural cost, not a cyclical one. We underwrite +12-15% annually for at least the first three years and assume no reversion. Then we pressure-test the year-three DSCR at that elevated number against the refi rate the curve implies.
If the deal only works on insurance reverting, it doesn't work. The repricing is structural — capacity has left these markets and isn't coming back at the old price.